News | August 11, 2021
Lupin posts net profit of Rs 542.46 cr. in Q1FY22
The profits were bolstered by the Boehringer Ingelheim MEK program income
The profits were bolstered by the Boehringer Ingelheim MEK program income
Formulation business grew by 15 per cent in the quarter
KIMS Hospitals' brand, has an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
Board approves fundraise of Rs 1500 crore
The company expects revenue growth of 10-15 per cent in the US
PAT rises to Rs 195.76 crore
This robust growth has come despite the raging pandemic for most part of the quarter
The company has been consistently reducing debt
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
